Horizon
Biotechnology ResearchIreland, Ireland1001-5000 Employees
Horizon Therapeutics is now part of Amgen. We encourage you to follow Amgen on LinkedIn at: https://bit.ly/3oPUyW4.
Competitive Landscape Insight Amgen Inc. faces competition from companies like Krazati in the biotechnology sector, highlighting the need for strategic differentiation in product offerings.
Investment Trends Insight Multiple investment firms, including Scissortail Wealth Management LLC, Lewis Asset Management LLC, and Capital Asset Advisory Services LLC, have shown interest in investing significant amounts in Amgen Inc., indicating potential partnerships or sales collaborations.
Strategic Alliances Insight Collaborations with educational institutions like Columbus State for biotech education and apprentice hires offer opportunities for market expansion through talent development and innovation partnerships.
Financial Health Insight With a revenue range of $100M - 1B and funding of $963M, Amgen Inc. demonstrates financial stability and potential for future growth and investment in cutting-edge biotechnology solutions.
Market Expansion Potential Insight With a focus on biotechnology research and a substantial employee base of 1001-5000, Amgen Inc. is positioned to explore new market opportunities and leverage technology advancements for sales growth.
Horizon uses 8 technology products and services including LinkedIn Recruiter, Apache Spark, SAS/GRAPH, and more. Explore Horizon's tech stack below.
Horizon Email Formats | Percentage |
flast@horizontherapeutics.com | 90% |
firstlast@horizontherapeutics.com | 5% |
first.last@horizontherapeutics.com | 2% |
first@horizontherapeutics.com | 0% |
fmiddlelast@horizontherapeutics.com | 1% |
filast@horizontherapeutics.com | 0% |
firlast@horizontherapeutics.com | 1% |
f_last@horizontherapeutics.com | 0% |
last.f@horizontherapeutics.com | 0% |
last_first@horizontherapeutics.com | 0% |
first-last@horizontherapeutics.com | 0% |
lastf@horizontherapeutics.com | 0% |
firstlas@horizontherapeutics.com | 1% |
lastfirst@horizontherapeutics.com | 0% |
fl@horizontherapeutics.com | 0% |
lfirst@horizontherapeutics.com | 0% |
fmlast@horizontherapeutics.com | 0% |
first.last@amgen.com | 46% |
flast@amgen.com | 46% |
firstl@amgen.com | 6% |
lastf@amgen.com | 2% |
Biotechnology ResearchIreland, Ireland1001-5000 Employees
Horizon Therapeutics is now part of Amgen. We encourage you to follow Amgen on LinkedIn at: https://bit.ly/3oPUyW4.
Horizon has raised a total of $963M of funding over 17 rounds. Their latest funding round was raised on Aug 06, 2020.
Horizon's revenue is in the range of $100M$1B
Horizon has raised a total of $963M of funding over 17 rounds. Their latest funding round was raised on Aug 06, 2020.
Horizon's revenue is in the range of $100M$1B
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.